Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Interim Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited)

v3.21.1
Condensed Interim Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Share Capital [Member]
Warrant Reserve [Member]
Contributed Surplus [Member]
Deficit [Member]
Total
Beginning balance at Dec. 31, 2019 $ 194,217 $ 642 $ 8,304 $ (214,845) $ (11,682)
Beginning balance, share at Dec. 31, 2019 39,907,681        
Statement Line Items [Line Items]          
Issued pursuant to agency agreement $ 3,037 3,037
Issued pursuant to agency agreement, shares 11,909,196        
March 2020 Equity Offering - broker warrants $ (26) 26    
Share issue expense (214) (214)
Warrants exercised during the quarter $ 1,011 1,011
Warrants exercised during the quarter, shares 2,400,000        
Stock-based compensation expense 229 229
Net loss (768) (768)
Ending balance at Mar. 31, 2020 $ 198,025 668 8,533 (215,613) (8,387)
Ending balance, shares at Mar. 31, 2020 54,216,877        
Beginning balance at Dec. 31, 2020 $ 214,148 1,671 9,401 (239,029) (13,809)
Beginning balance, share at Dec. 31, 2020 83,184,843        
Statement Line Items [Line Items]          
Derivative warrants exercised $ 8,000 8,000
Derivative warrants exercised, shares 8,000,000        
Derivative warrants exercised - fair value adjustment $ 15,722 15,722
January 2021 Equity Offering, net of issuance costs $ 7,067 3,164 10,231
January 2021 Equity Offering, net of issuance costs, shares 7,419,354        
January 2021 Equity Offering-broker warrants $ (1,384) 1,384
February 2021 Equity Offering, net of issuance costs $ 15,165 5,928 21,093
February 2021 Equity Offering, net of issuance costs, shares 9,585,250        
February 2021 Equity Offering-broker warrants $ (1,238) 1,238
Equity warrants exercised $ 1,985 1,985
Equity warrants exercised, shares 1,318,675        
Options exercised $ 27 (13) 14
Options exercised, shares 19,568        
Stock-based compensation expense 769 769
Net loss (14,794) (14,794)
Ending balance at Mar. 31, 2021 $ 259,492 $ 13,385 $ 10,157 $ (253,823) $ 29,211
Ending balance, shares at Mar. 31, 2021 109,527,690       109,527,690